Cargando…
Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making
OBJECTIVE: In 2020, we developed a public health decision‐support model for mitigating the spread of SARS‐CoV‐2 infections in Australia and New Zealand. Having demonstrated its capacity to describe disease progression patterns during both countries’ first waves of infections, we describe its utilisa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111129/ https://www.ncbi.nlm.nih.gov/pubmed/35238437 http://dx.doi.org/10.1111/1753-6405.13221 |
_version_ | 1784709238698803200 |
---|---|
author | Thompson, Jason McClure, Rod Blakely, Tony Wilson, Nick Baker, Michael G. Wijnands, Jasper S. De Sa, Thiago Herick Nice, Kerry Cruz, Camilo Stevenson, Mark |
author_facet | Thompson, Jason McClure, Rod Blakely, Tony Wilson, Nick Baker, Michael G. Wijnands, Jasper S. De Sa, Thiago Herick Nice, Kerry Cruz, Camilo Stevenson, Mark |
author_sort | Thompson, Jason |
collection | PubMed |
description | OBJECTIVE: In 2020, we developed a public health decision‐support model for mitigating the spread of SARS‐CoV‐2 infections in Australia and New Zealand. Having demonstrated its capacity to describe disease progression patterns during both countries’ first waves of infections, we describe its utilisation in Victoria in underpinning the State Government's then ‘RoadMap to Reopening’. METHODS: Key aspects of population demographics, disease, spatial and behavioural dynamics, as well as the mechanism, timing, and effect of non‐pharmaceutical public health policies responses on the transmission of SARS‐CoV‐2 in both countries were represented in an agent‐based model. We considered scenarios related to the imposition and removal of non‐pharmaceutical interventions on the estimated progression of SARS‐CoV‐2 infections. RESULTS: Wave 1 results suggested elimination of community transmission of SARS‐CoV‐2 was possible in both countries given sustained public adherence to social restrictions beyond 60 days’ duration. However, under scenarios of decaying adherence to restrictions, a second wave of infections (Wave 2) was predicted in Australia. In Victoria’s second wave, we estimated in early September 2020 that a rolling 14‐day average of <5 new cases per day was achievable on or around 26 October. Victoria recorded a 14‐day rolling average of 4.6 cases per day on 25 October. CONCLUSIONS: Elimination of SARS‐CoV‐2 transmission represented in faithfully constructed agent‐based models can be replicated in the real world. IMPLICATIONS FOR PUBLIC HEALTH: Agent‐based public health policy models can be helpful to support decision‐making in novel and complex unfolding public health crises. |
format | Online Article Text |
id | pubmed-9111129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91111292022-05-17 Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making Thompson, Jason McClure, Rod Blakely, Tony Wilson, Nick Baker, Michael G. Wijnands, Jasper S. De Sa, Thiago Herick Nice, Kerry Cruz, Camilo Stevenson, Mark Aust N Z J Public Health Covid‐19 OBJECTIVE: In 2020, we developed a public health decision‐support model for mitigating the spread of SARS‐CoV‐2 infections in Australia and New Zealand. Having demonstrated its capacity to describe disease progression patterns during both countries’ first waves of infections, we describe its utilisation in Victoria in underpinning the State Government's then ‘RoadMap to Reopening’. METHODS: Key aspects of population demographics, disease, spatial and behavioural dynamics, as well as the mechanism, timing, and effect of non‐pharmaceutical public health policies responses on the transmission of SARS‐CoV‐2 in both countries were represented in an agent‐based model. We considered scenarios related to the imposition and removal of non‐pharmaceutical interventions on the estimated progression of SARS‐CoV‐2 infections. RESULTS: Wave 1 results suggested elimination of community transmission of SARS‐CoV‐2 was possible in both countries given sustained public adherence to social restrictions beyond 60 days’ duration. However, under scenarios of decaying adherence to restrictions, a second wave of infections (Wave 2) was predicted in Australia. In Victoria’s second wave, we estimated in early September 2020 that a rolling 14‐day average of <5 new cases per day was achievable on or around 26 October. Victoria recorded a 14‐day rolling average of 4.6 cases per day on 25 October. CONCLUSIONS: Elimination of SARS‐CoV‐2 transmission represented in faithfully constructed agent‐based models can be replicated in the real world. IMPLICATIONS FOR PUBLIC HEALTH: Agent‐based public health policy models can be helpful to support decision‐making in novel and complex unfolding public health crises. Elsevier 2022-06 2023-02-27 /pmc/articles/PMC9111129/ /pubmed/35238437 http://dx.doi.org/10.1111/1753-6405.13221 Text en © 2022 Copyright 2022 THE AUTHORS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Covid‐19 Thompson, Jason McClure, Rod Blakely, Tony Wilson, Nick Baker, Michael G. Wijnands, Jasper S. De Sa, Thiago Herick Nice, Kerry Cruz, Camilo Stevenson, Mark Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title | Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title_full | Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title_fullStr | Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title_full_unstemmed | Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title_short | Modelling SARS‐CoV‐2 disease progression in Australia and New Zealand: an account of an agent‐based approach to support public health decision‐making |
title_sort | modelling sars‐cov‐2 disease progression in australia and new zealand: an account of an agent‐based approach to support public health decision‐making |
topic | Covid‐19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111129/ https://www.ncbi.nlm.nih.gov/pubmed/35238437 http://dx.doi.org/10.1111/1753-6405.13221 |
work_keys_str_mv | AT thompsonjason modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT mcclurerod modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT blakelytony modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT wilsonnick modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT bakermichaelg modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT wijnandsjaspers modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT desathiagoherick modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT nicekerry modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT cruzcamilo modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking AT stevensonmark modellingsarscov2diseaseprogressioninaustraliaandnewzealandanaccountofanagentbasedapproachtosupportpublichealthdecisionmaking |